Zealand Pharma A-S News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.05.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
23.05.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
12.05.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
11.05.23	Zealand Pharma Announces Financial Results for the First Quarter of 2023 (GlobeNewswire)
10.05.23	Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight (GlobeNewswire)
28.04.23	Total number of shares and voting rights in Zealand Pharma at April 28, 2023 (GlobeNewswire)
25.04.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23	Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 (GlobeNewswire)
04.04.23	Zealand Pharma completes registration of capital increase (GlobeNewswire)
03.04.23	Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen (GlobeNewswire)
31.03.23	Total number of shares and voting rights in Zealand Pharma at March 31, 2023 (GlobeNewswire)
30.03.23	Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion (GlobeNewswire)
30.03.23	Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares (GlobeNewswire)
28.03.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
28.03.23	Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 (GlobeNewswire)
13.03.23	Zealand Pharma Provides Update on Silicon Valley Bank Closure (GlobeNewswire)
12.03.23	Zealand Pharma Provides Statement on Silicon Valley Bank Closure (GlobeNewswire)
10.03.23	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
09.03.23	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
02.03.23	Zealand Pharma convenes its Annual General Meeting 2023 (GlobeNewswire)
02.03.23	Zealand Pharma Announces Full Year Results for 2022 (GlobeNewswire)
17.11.22	Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
17.11.22	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
08.11.22	Zealand Pharma to Participate in Upcoming Investor Conferences (GlobeNewswire)
03.11.22	Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 (GlobeNewswire)
31.10.22	Total number of shares and voting rights in Zealand Pharma at October 31, 2022 (GlobeNewswire)
21.09.22	Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) (GlobeNewswire)
19.09.22	Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting (GlobeNewswire)
07.09.22	Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire)
04.08.22	Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022 (GlobeNewswire)
03.06.22	Zealand Pharma to Participate in Upcoming Investor Conferences (GlobeNewswire)
02.06.22	Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer (GlobeNewswire)
11.05.22	Ausblick: Zealand Pharma A-S gewährt Anlegern Blick in die Bücher (finanzen.net)
05.05.22	Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022 (GlobeNewswire)
27.04.22	Erste Schätzungen: Zealand Pharma A-S zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
04.04.22	Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
09.03.22	Ausblick: Zealand Pharma A-S präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
03.03.22	Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full Year Results for 2021 (GlobeNewswire)
23.02.22	Erste Schätzungen: Zealand Pharma A-S vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
03.01.22	Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference (GlobeNewswire)
16.12.21	Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome (GlobeNewswire)
12.11.21	Zealand Pharma to Participate in Jefferies London Healthcare Conference (GlobeNewswire)
10.11.21	Ausblick: Zealand Pharma A-S gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
04.11.21	Zealand Pharma Hosts Conference Call on November 11 at 4 pm CET (10 am ET) to Present Third Quarter Results for 2021 (GlobeNewswire)
27.10.21	Erste Schätzungen: Zealand Pharma A-S stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
03.09.21	Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference (GlobeNewswire)
31.08.21	Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium (GlobeNewswire)
19.08.21	Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome (GlobeNewswire)
10.08.21	Ausblick: Zealand Pharma A-S stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Zealand Pharma A-S

Aktien Top/Flop

Meistgelesene Nachrichten